Panbela Therapeutics Inc (PBLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 5,877 | 4,860 | 5,180 | 3,623 | 21,286 |
| Operating Income | -5,877 | -4,860 | -5,180 | -3,623 | -21,286 |
| Interest Expense | 70 | 102 | 182 | 87 | 16 |
| Other Income | -33 | -151 | 614 | -748 | -846 |
| Pre-tax Income | -5,980 | -5,113 | -4,748 | -4,458 | -22,148 |
| Income Tax | -147 | N/A | -13 | -56 | -18 |
| Net Income Continuous | -5,833 | -5,113 | -4,735 | -4,402 | -22,130 |
| Net Income | $-5,833 | $-5,113 | $-4,735 | $-4,402 | $-22,130 |
| EPS Basic Total Ops | -159.15 | -392.76 | 7,232.14 | -5,147.20 | -36,873.60 |
| EPS Basic Continuous Ops | -157.65 | -393.31 | 7,241.92 | -5,146.43 | -36,883.34 |
| EPS Diluted Total Ops | -159.15 | -392.76 | 7,232.14 | -5,147.20 | -36,873.60 |
| EPS Diluted Continuous Ops | -157.65 | -393.31 | 7,241.92 | -5,146.43 | -36,883.34 |
| EPS Diluted Before Non-Recurring Items | -159.00 | -390.39 | -3,411.41 | N/A | N/A |
| EBITDA(a) | $-5,877 | $-4,860 | $-5,180 | $-3,623 | $-21,286 |